tetano
Editor, Senior Moderator
Cureus
. 2022 Jan 19;14(1):e21413.
doi: 10.7759/cureus.21413. eCollection 2022 Jan.
Study of Disease Severity and Outcomes in COVID-19 Patients With Chronic Kidney Disease at a Tertiary Care Hospital in South India
Pranav Ramamurthy[SUP] 1 [/SUP], Rajashekhar R[SUP] 2 [/SUP], Ashwin Kulkarni[SUP] 3 [/SUP], Divya Prabhu[SUP] 1 [/SUP], Anil Kumar[SUP] 1 [/SUP], Rahul Ravindra[SUP] 1 [/SUP], Prakriti Ramamurthy[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Coronavirus disease 2019 (COVID-19) disproportionately affects individuals with various comorbidities. Among these, chronic kidney disease (CKD) has been shown to be strongly associated with the progression to severe disease. This study aimed to assess the severity and disease outcomes in patients with COVID-19 infection and CKD.
Methods: This is a retrospective study conducted at a tertiary care hospital from July 2021 to September 2021. The case records of patients with CKD and COVID-19 were studied. They were compared with age and gender-matched controls equally. The presenting symptoms, clinical course, severity of illness, laboratory markers, need for ventilator support, and mortality outcomes were studied.
Results: In total, 40 CKD and 40 non-CKD patients with COVID-19 were included in the study. It was also observed that among the patients with CKD, more patients had fever, breathlessness, and diarrhea. The requirement for noninvasive ventilation, ventilator, and inotropes was on the higher average for patients with CKD. Overall mortality was 27.5% in the CKD group and 2.5% in the non-CKD group, which was statistically significant (p = 0.002).
Conclusions: COVID-19 patients with CKD had more severe illnesses with a requirement of ventilator support and had higher mortality than the patients without CKD. Patients with CKD are a key subset of patients with COVID-19 for whom more aggressive early treatment and stricter preventive measures may be beneficial.
Keywords: chronic kidney disease; covid-19 mortality; covid-19 severity; ct severity; infection.
. 2022 Jan 19;14(1):e21413.
doi: 10.7759/cureus.21413. eCollection 2022 Jan.
Study of Disease Severity and Outcomes in COVID-19 Patients With Chronic Kidney Disease at a Tertiary Care Hospital in South India
Pranav Ramamurthy[SUP] 1 [/SUP], Rajashekhar R[SUP] 2 [/SUP], Ashwin Kulkarni[SUP] 3 [/SUP], Divya Prabhu[SUP] 1 [/SUP], Anil Kumar[SUP] 1 [/SUP], Rahul Ravindra[SUP] 1 [/SUP], Prakriti Ramamurthy[SUP] 1 [/SUP]
Affiliations
- PMID: 35103220
- PMCID: PMC8769075
- DOI: 10.7759/cureus.21413
Abstract
Background: Coronavirus disease 2019 (COVID-19) disproportionately affects individuals with various comorbidities. Among these, chronic kidney disease (CKD) has been shown to be strongly associated with the progression to severe disease. This study aimed to assess the severity and disease outcomes in patients with COVID-19 infection and CKD.
Methods: This is a retrospective study conducted at a tertiary care hospital from July 2021 to September 2021. The case records of patients with CKD and COVID-19 were studied. They were compared with age and gender-matched controls equally. The presenting symptoms, clinical course, severity of illness, laboratory markers, need for ventilator support, and mortality outcomes were studied.
Results: In total, 40 CKD and 40 non-CKD patients with COVID-19 were included in the study. It was also observed that among the patients with CKD, more patients had fever, breathlessness, and diarrhea. The requirement for noninvasive ventilation, ventilator, and inotropes was on the higher average for patients with CKD. Overall mortality was 27.5% in the CKD group and 2.5% in the non-CKD group, which was statistically significant (p = 0.002).
Conclusions: COVID-19 patients with CKD had more severe illnesses with a requirement of ventilator support and had higher mortality than the patients without CKD. Patients with CKD are a key subset of patients with COVID-19 for whom more aggressive early treatment and stricter preventive measures may be beneficial.
Keywords: chronic kidney disease; covid-19 mortality; covid-19 severity; ct severity; infection.